Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/azad-says-no-shortage-of-tb-drugs-who-for-regimen-change-aarti-dhar-21653/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/azad-says-no-shortage-of-tb-drugs-who-for-regimen-change-aarti-dhar-21653/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/azad-says-no-shortage-of-tb-drugs-who-for-regimen-change-aarti-dhar-21653/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/azad-says-no-shortage-of-tb-drugs-who-for-regimen-change-aarti-dhar-21653/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2478394a55-trace').style.display = (document.getElementById('cakeErr67f2478394a55-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f2478394a55-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2478394a55-code').style.display = (document.getElementById('cakeErr67f2478394a55-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2478394a55-context').style.display = (document.getElementById('cakeErr67f2478394a55-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f2478394a55-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f2478394a55-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 21506,
		&#039;title&#039; =&gt; &#039;Azad says no shortage of TB drugs; WHO for regimen change-Aarti Dhar&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
One of the challenges in anti-TB drugs procurement is that only a few manufacturers produce the particular regimen used by India&#039;s programme, which is of intermittent schedule. &amp;quot;WHO currently recommends governments to consider changing the regimen from intermittent to daily,&amp;quot; WHO Representative to India Nata Menabde said in a statement issued here.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
WHO understood there was no drugs stock-out for adult patients for both drug-sensitive and drug-resistant TB at present. However, there was a dip in the buffer stock of drugs. &amp;quot;We understand that the government has initiated steps to ensure replenishment. Also the stock of paediatric drugs, which is critically low, is being augmented through emergency procurement,&amp;quot; Dr. Menadbe said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Health and Family Welfare Minister Ghulam Nabi Azad said, &amp;quot;At present there is no shortage. We always keep standby arrangements and we are providing medicines from that stock. Orders have been placed and within a month supplies will be made available to the States,&amp;quot; he said after inaugurating a private ward at the LRS Institute of Tuberculosis and Respiratory Diseases here.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
He, however, acknowledged that despite socio-economic development and advances in medical science, tuberculosis still remained a major public health concern globally.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Drug resistance
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Another challenge of great concern, Mr Azad said, was the growing resistance to drugs due to irregular and incomplete treatment with irrational regimens. &amp;quot;This is being dealt with through appropriate expansion of diagnostic and treatment services.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
However, WHO said that for patients who had started treatment, India&#039;s programme provided one full course of drugs for each patient. This ensured that there was no interruption of treatment due to drug shortage. Hence, the fear that there could be interruption of treatment leading to development of drug resistance was unfounded. &amp;quot;It is reassuring to note that the Government of India has taken urgent action,&amp;quot; Dr. Menabde said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
India has one of the largest TB control programmes in the world with nearly 1.5 million patients placed under treatment every year. The treatment protocol ensures that the whole course of anti-TB drugs is given free of cost to patients with intense monitoring and other patient support systems.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Since inception, the Revised National TB Control Programme has evaluated over 55 million persons for TB and initiated treatment for over 15.8 million patients. There has never been any shortage of drugs in the programme due to a robust drug forecasting, procurement and distribution system
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The programme ventured on a rapid scale-up for rolling out drug-resistant TB management services and by March 2013 this service was made available to the entire population of the country. 
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu, 21 June, 2013, http://www.thehindu.com/sci-tech/health/medicine-and-research/no-shortage-of-tuberculosis-drugs-azad/article4837233.ece?homepage=true&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;azad-says-no-shortage-of-tb-drugs-who-for-regimen-change-aarti-dhar-21653&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 21653,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 21506,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Azad says no shortage of TB drugs; WHO for regimen change-Aarti Dhar&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Tuberculosis,Health,medicines&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Hindu



Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.


One of the...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;One of the challenges in anti-TB drugs procurement is that only a few manufacturers produce the particular regimen used by India&#039;s programme, which is of intermittent schedule. &amp;quot;WHO currently recommends governments to consider changing the regimen from intermittent to daily,&amp;quot; WHO Representative to India Nata Menabde said in a statement issued here.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;WHO understood there was no drugs stock-out for adult patients for both drug-sensitive and drug-resistant TB at present. However, there was a dip in the buffer stock of drugs. &amp;quot;We understand that the government has initiated steps to ensure replenishment. Also the stock of paediatric drugs, which is critically low, is being augmented through emergency procurement,&amp;quot; Dr. Menadbe said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Health and Family Welfare Minister Ghulam Nabi Azad said, &amp;quot;At present there is no shortage. We always keep standby arrangements and we are providing medicines from that stock. Orders have been placed and within a month supplies will be made available to the States,&amp;quot; he said after inaugurating a private ward at the LRS Institute of Tuberculosis and Respiratory Diseases here.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;He, however, acknowledged that despite socio-economic development and advances in medical science, tuberculosis still remained a major public health concern globally.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Drug resistance&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Another challenge of great concern, Mr Azad said, was the growing resistance to drugs due to irregular and incomplete treatment with irrational regimens. &amp;quot;This is being dealt with through appropriate expansion of diagnostic and treatment services.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;However, WHO said that for patients who had started treatment, India&#039;s programme provided one full course of drugs for each patient. This ensured that there was no interruption of treatment due to drug shortage. Hence, the fear that there could be interruption of treatment leading to development of drug resistance was unfounded. &amp;quot;It is reassuring to note that the Government of India has taken urgent action,&amp;quot; Dr. Menabde said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;India has one of the largest TB control programmes in the world with nearly 1.5 million patients placed under treatment every year. The treatment protocol ensures that the whole course of anti-TB drugs is given free of cost to patients with intense monitoring and other patient support systems.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Since inception, the Revised National TB Control Programme has evaluated over 55 million persons for TB and initiated treatment for over 15.8 million patients. There has never been any shortage of drugs in the programme due to a robust drug forecasting, procurement and distribution system&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The programme ventured on a rapid scale-up for rolling out drug-resistant TB management services and by March 2013 this service was made available to the entire population of the country. &lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 21506,
	&#039;title&#039; =&gt; &#039;Azad says no shortage of TB drugs; WHO for regimen change-Aarti Dhar&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
One of the challenges in anti-TB drugs procurement is that only a few manufacturers produce the particular regimen used by India&#039;s programme, which is of intermittent schedule. &amp;quot;WHO currently recommends governments to consider changing the regimen from intermittent to daily,&amp;quot; WHO Representative to India Nata Menabde said in a statement issued here.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
WHO understood there was no drugs stock-out for adult patients for both drug-sensitive and drug-resistant TB at present. However, there was a dip in the buffer stock of drugs. &amp;quot;We understand that the government has initiated steps to ensure replenishment. Also the stock of paediatric drugs, which is critically low, is being augmented through emergency procurement,&amp;quot; Dr. Menadbe said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Health and Family Welfare Minister Ghulam Nabi Azad said, &amp;quot;At present there is no shortage. We always keep standby arrangements and we are providing medicines from that stock. Orders have been placed and within a month supplies will be made available to the States,&amp;quot; he said after inaugurating a private ward at the LRS Institute of Tuberculosis and Respiratory Diseases here.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
He, however, acknowledged that despite socio-economic development and advances in medical science, tuberculosis still remained a major public health concern globally.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Drug resistance
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Another challenge of great concern, Mr Azad said, was the growing resistance to drugs due to irregular and incomplete treatment with irrational regimens. &amp;quot;This is being dealt with through appropriate expansion of diagnostic and treatment services.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
However, WHO said that for patients who had started treatment, India&#039;s programme provided one full course of drugs for each patient. This ensured that there was no interruption of treatment due to drug shortage. Hence, the fear that there could be interruption of treatment leading to development of drug resistance was unfounded. &amp;quot;It is reassuring to note that the Government of India has taken urgent action,&amp;quot; Dr. Menabde said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
India has one of the largest TB control programmes in the world with nearly 1.5 million patients placed under treatment every year. The treatment protocol ensures that the whole course of anti-TB drugs is given free of cost to patients with intense monitoring and other patient support systems.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Since inception, the Revised National TB Control Programme has evaluated over 55 million persons for TB and initiated treatment for over 15.8 million patients. There has never been any shortage of drugs in the programme due to a robust drug forecasting, procurement and distribution system
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The programme ventured on a rapid scale-up for rolling out drug-resistant TB management services and by March 2013 this service was made available to the entire population of the country. 
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu, 21 June, 2013, http://www.thehindu.com/sci-tech/health/medicine-and-research/no-shortage-of-tuberculosis-drugs-azad/article4837233.ece?homepage=true&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;azad-says-no-shortage-of-tb-drugs-who-for-regimen-change-aarti-dhar-21653&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 21653,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 21506
$metaTitle = &#039;LATEST NEWS UPDATES | Azad says no shortage of TB drugs; WHO for regimen change-Aarti Dhar&#039;
$metaKeywords = &#039;Tuberculosis,Health,medicines&#039;
$metaDesc = &#039;
-The Hindu



Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.


One of the...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;One of the challenges in anti-TB drugs procurement is that only a few manufacturers produce the particular regimen used by India&#039;s programme, which is of intermittent schedule. &amp;quot;WHO currently recommends governments to consider changing the regimen from intermittent to daily,&amp;quot; WHO Representative to India Nata Menabde said in a statement issued here.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;WHO understood there was no drugs stock-out for adult patients for both drug-sensitive and drug-resistant TB at present. However, there was a dip in the buffer stock of drugs. &amp;quot;We understand that the government has initiated steps to ensure replenishment. Also the stock of paediatric drugs, which is critically low, is being augmented through emergency procurement,&amp;quot; Dr. Menadbe said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Health and Family Welfare Minister Ghulam Nabi Azad said, &amp;quot;At present there is no shortage. We always keep standby arrangements and we are providing medicines from that stock. Orders have been placed and within a month supplies will be made available to the States,&amp;quot; he said after inaugurating a private ward at the LRS Institute of Tuberculosis and Respiratory Diseases here.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;He, however, acknowledged that despite socio-economic development and advances in medical science, tuberculosis still remained a major public health concern globally.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Drug resistance&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Another challenge of great concern, Mr Azad said, was the growing resistance to drugs due to irregular and incomplete treatment with irrational regimens. &amp;quot;This is being dealt with through appropriate expansion of diagnostic and treatment services.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;However, WHO said that for patients who had started treatment, India&#039;s programme provided one full course of drugs for each patient. This ensured that there was no interruption of treatment due to drug shortage. Hence, the fear that there could be interruption of treatment leading to development of drug resistance was unfounded. &amp;quot;It is reassuring to note that the Government of India has taken urgent action,&amp;quot; Dr. Menabde said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;India has one of the largest TB control programmes in the world with nearly 1.5 million patients placed under treatment every year. The treatment protocol ensures that the whole course of anti-TB drugs is given free of cost to patients with intense monitoring and other patient support systems.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Since inception, the Revised National TB Control Programme has evaluated over 55 million persons for TB and initiated treatment for over 15.8 million patients. There has never been any shortage of drugs in the programme due to a robust drug forecasting, procurement and distribution system&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The programme ventured on a rapid scale-up for rolling out drug-resistant TB management services and by March 2013 this service was made available to the entire population of the country. &lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/azad-says-no-shortage-of-tb-drugs-who-for-regimen-change-aarti-dhar-21653.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Azad says no shortage of TB drugs; WHO for regimen change-Aarti Dhar | Im4change.org</title>
    <meta name="description" content="
-The Hindu



Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.


One of the..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Azad says no shortage of TB drugs; WHO for regimen change-Aarti Dhar</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Hindu</div><p align="justify"><br />Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.</p><p align="justify">One of the challenges in anti-TB drugs procurement is that only a few manufacturers produce the particular regimen used by India's programme, which is of intermittent schedule. &quot;WHO currently recommends governments to consider changing the regimen from intermittent to daily,&quot; WHO Representative to India Nata Menabde said in a statement issued here.</p><p align="justify">WHO understood there was no drugs stock-out for adult patients for both drug-sensitive and drug-resistant TB at present. However, there was a dip in the buffer stock of drugs. &quot;We understand that the government has initiated steps to ensure replenishment. Also the stock of paediatric drugs, which is critically low, is being augmented through emergency procurement,&quot; Dr. Menadbe said.</p><p align="justify">Health and Family Welfare Minister Ghulam Nabi Azad said, &quot;At present there is no shortage. We always keep standby arrangements and we are providing medicines from that stock. Orders have been placed and within a month supplies will be made available to the States,&quot; he said after inaugurating a private ward at the LRS Institute of Tuberculosis and Respiratory Diseases here.</p><p align="justify">He, however, acknowledged that despite socio-economic development and advances in medical science, tuberculosis still remained a major public health concern globally.</p><p align="justify">Drug resistance</p><p align="justify">Another challenge of great concern, Mr Azad said, was the growing resistance to drugs due to irregular and incomplete treatment with irrational regimens. &quot;This is being dealt with through appropriate expansion of diagnostic and treatment services.&quot;</p><p align="justify">However, WHO said that for patients who had started treatment, India's programme provided one full course of drugs for each patient. This ensured that there was no interruption of treatment due to drug shortage. Hence, the fear that there could be interruption of treatment leading to development of drug resistance was unfounded. &quot;It is reassuring to note that the Government of India has taken urgent action,&quot; Dr. Menabde said.</p><p align="justify">India has one of the largest TB control programmes in the world with nearly 1.5 million patients placed under treatment every year. The treatment protocol ensures that the whole course of anti-TB drugs is given free of cost to patients with intense monitoring and other patient support systems.</p><p align="justify">Since inception, the Revised National TB Control Programme has evaluated over 55 million persons for TB and initiated treatment for over 15.8 million patients. There has never been any shortage of drugs in the programme due to a robust drug forecasting, procurement and distribution system</p><p align="justify">The programme ventured on a rapid scale-up for rolling out drug-resistant TB management services and by March 2013 this service was made available to the entire population of the country. </p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2478394a55-trace').style.display = (document.getElementById('cakeErr67f2478394a55-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f2478394a55-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2478394a55-code').style.display = (document.getElementById('cakeErr67f2478394a55-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2478394a55-context').style.display = (document.getElementById('cakeErr67f2478394a55-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f2478394a55-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f2478394a55-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 21506,
		&#039;title&#039; =&gt; &#039;Azad says no shortage of TB drugs; WHO for regimen change-Aarti Dhar&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
One of the challenges in anti-TB drugs procurement is that only a few manufacturers produce the particular regimen used by India&#039;s programme, which is of intermittent schedule. &amp;quot;WHO currently recommends governments to consider changing the regimen from intermittent to daily,&amp;quot; WHO Representative to India Nata Menabde said in a statement issued here.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
WHO understood there was no drugs stock-out for adult patients for both drug-sensitive and drug-resistant TB at present. However, there was a dip in the buffer stock of drugs. &amp;quot;We understand that the government has initiated steps to ensure replenishment. Also the stock of paediatric drugs, which is critically low, is being augmented through emergency procurement,&amp;quot; Dr. Menadbe said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Health and Family Welfare Minister Ghulam Nabi Azad said, &amp;quot;At present there is no shortage. We always keep standby arrangements and we are providing medicines from that stock. Orders have been placed and within a month supplies will be made available to the States,&amp;quot; he said after inaugurating a private ward at the LRS Institute of Tuberculosis and Respiratory Diseases here.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
He, however, acknowledged that despite socio-economic development and advances in medical science, tuberculosis still remained a major public health concern globally.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Drug resistance
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Another challenge of great concern, Mr Azad said, was the growing resistance to drugs due to irregular and incomplete treatment with irrational regimens. &amp;quot;This is being dealt with through appropriate expansion of diagnostic and treatment services.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
However, WHO said that for patients who had started treatment, India&#039;s programme provided one full course of drugs for each patient. This ensured that there was no interruption of treatment due to drug shortage. Hence, the fear that there could be interruption of treatment leading to development of drug resistance was unfounded. &amp;quot;It is reassuring to note that the Government of India has taken urgent action,&amp;quot; Dr. Menabde said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
India has one of the largest TB control programmes in the world with nearly 1.5 million patients placed under treatment every year. The treatment protocol ensures that the whole course of anti-TB drugs is given free of cost to patients with intense monitoring and other patient support systems.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Since inception, the Revised National TB Control Programme has evaluated over 55 million persons for TB and initiated treatment for over 15.8 million patients. There has never been any shortage of drugs in the programme due to a robust drug forecasting, procurement and distribution system
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The programme ventured on a rapid scale-up for rolling out drug-resistant TB management services and by March 2013 this service was made available to the entire population of the country. 
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu, 21 June, 2013, http://www.thehindu.com/sci-tech/health/medicine-and-research/no-shortage-of-tuberculosis-drugs-azad/article4837233.ece?homepage=true&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;azad-says-no-shortage-of-tb-drugs-who-for-regimen-change-aarti-dhar-21653&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 21653,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 21506,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Azad says no shortage of TB drugs; WHO for regimen change-Aarti Dhar&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Tuberculosis,Health,medicines&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Hindu



Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.


One of the...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;One of the challenges in anti-TB drugs procurement is that only a few manufacturers produce the particular regimen used by India&#039;s programme, which is of intermittent schedule. &amp;quot;WHO currently recommends governments to consider changing the regimen from intermittent to daily,&amp;quot; WHO Representative to India Nata Menabde said in a statement issued here.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;WHO understood there was no drugs stock-out for adult patients for both drug-sensitive and drug-resistant TB at present. However, there was a dip in the buffer stock of drugs. &amp;quot;We understand that the government has initiated steps to ensure replenishment. Also the stock of paediatric drugs, which is critically low, is being augmented through emergency procurement,&amp;quot; Dr. Menadbe said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Health and Family Welfare Minister Ghulam Nabi Azad said, &amp;quot;At present there is no shortage. We always keep standby arrangements and we are providing medicines from that stock. Orders have been placed and within a month supplies will be made available to the States,&amp;quot; he said after inaugurating a private ward at the LRS Institute of Tuberculosis and Respiratory Diseases here.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;He, however, acknowledged that despite socio-economic development and advances in medical science, tuberculosis still remained a major public health concern globally.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Drug resistance&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Another challenge of great concern, Mr Azad said, was the growing resistance to drugs due to irregular and incomplete treatment with irrational regimens. &amp;quot;This is being dealt with through appropriate expansion of diagnostic and treatment services.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;However, WHO said that for patients who had started treatment, India&#039;s programme provided one full course of drugs for each patient. This ensured that there was no interruption of treatment due to drug shortage. Hence, the fear that there could be interruption of treatment leading to development of drug resistance was unfounded. &amp;quot;It is reassuring to note that the Government of India has taken urgent action,&amp;quot; Dr. Menabde said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;India has one of the largest TB control programmes in the world with nearly 1.5 million patients placed under treatment every year. The treatment protocol ensures that the whole course of anti-TB drugs is given free of cost to patients with intense monitoring and other patient support systems.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Since inception, the Revised National TB Control Programme has evaluated over 55 million persons for TB and initiated treatment for over 15.8 million patients. There has never been any shortage of drugs in the programme due to a robust drug forecasting, procurement and distribution system&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The programme ventured on a rapid scale-up for rolling out drug-resistant TB management services and by March 2013 this service was made available to the entire population of the country. &lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 21506,
	&#039;title&#039; =&gt; &#039;Azad says no shortage of TB drugs; WHO for regimen change-Aarti Dhar&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
One of the challenges in anti-TB drugs procurement is that only a few manufacturers produce the particular regimen used by India&#039;s programme, which is of intermittent schedule. &amp;quot;WHO currently recommends governments to consider changing the regimen from intermittent to daily,&amp;quot; WHO Representative to India Nata Menabde said in a statement issued here.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
WHO understood there was no drugs stock-out for adult patients for both drug-sensitive and drug-resistant TB at present. However, there was a dip in the buffer stock of drugs. &amp;quot;We understand that the government has initiated steps to ensure replenishment. Also the stock of paediatric drugs, which is critically low, is being augmented through emergency procurement,&amp;quot; Dr. Menadbe said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Health and Family Welfare Minister Ghulam Nabi Azad said, &amp;quot;At present there is no shortage. We always keep standby arrangements and we are providing medicines from that stock. Orders have been placed and within a month supplies will be made available to the States,&amp;quot; he said after inaugurating a private ward at the LRS Institute of Tuberculosis and Respiratory Diseases here.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
He, however, acknowledged that despite socio-economic development and advances in medical science, tuberculosis still remained a major public health concern globally.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Drug resistance
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Another challenge of great concern, Mr Azad said, was the growing resistance to drugs due to irregular and incomplete treatment with irrational regimens. &amp;quot;This is being dealt with through appropriate expansion of diagnostic and treatment services.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
However, WHO said that for patients who had started treatment, India&#039;s programme provided one full course of drugs for each patient. This ensured that there was no interruption of treatment due to drug shortage. Hence, the fear that there could be interruption of treatment leading to development of drug resistance was unfounded. &amp;quot;It is reassuring to note that the Government of India has taken urgent action,&amp;quot; Dr. Menabde said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
India has one of the largest TB control programmes in the world with nearly 1.5 million patients placed under treatment every year. The treatment protocol ensures that the whole course of anti-TB drugs is given free of cost to patients with intense monitoring and other patient support systems.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Since inception, the Revised National TB Control Programme has evaluated over 55 million persons for TB and initiated treatment for over 15.8 million patients. There has never been any shortage of drugs in the programme due to a robust drug forecasting, procurement and distribution system
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The programme ventured on a rapid scale-up for rolling out drug-resistant TB management services and by March 2013 this service was made available to the entire population of the country. 
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu, 21 June, 2013, http://www.thehindu.com/sci-tech/health/medicine-and-research/no-shortage-of-tuberculosis-drugs-azad/article4837233.ece?homepage=true&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;azad-says-no-shortage-of-tb-drugs-who-for-regimen-change-aarti-dhar-21653&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 21653,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 21506
$metaTitle = &#039;LATEST NEWS UPDATES | Azad says no shortage of TB drugs; WHO for regimen change-Aarti Dhar&#039;
$metaKeywords = &#039;Tuberculosis,Health,medicines&#039;
$metaDesc = &#039;
-The Hindu



Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.


One of the...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;One of the challenges in anti-TB drugs procurement is that only a few manufacturers produce the particular regimen used by India&#039;s programme, which is of intermittent schedule. &amp;quot;WHO currently recommends governments to consider changing the regimen from intermittent to daily,&amp;quot; WHO Representative to India Nata Menabde said in a statement issued here.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;WHO understood there was no drugs stock-out for adult patients for both drug-sensitive and drug-resistant TB at present. However, there was a dip in the buffer stock of drugs. &amp;quot;We understand that the government has initiated steps to ensure replenishment. Also the stock of paediatric drugs, which is critically low, is being augmented through emergency procurement,&amp;quot; Dr. Menadbe said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Health and Family Welfare Minister Ghulam Nabi Azad said, &amp;quot;At present there is no shortage. We always keep standby arrangements and we are providing medicines from that stock. Orders have been placed and within a month supplies will be made available to the States,&amp;quot; he said after inaugurating a private ward at the LRS Institute of Tuberculosis and Respiratory Diseases here.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;He, however, acknowledged that despite socio-economic development and advances in medical science, tuberculosis still remained a major public health concern globally.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Drug resistance&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Another challenge of great concern, Mr Azad said, was the growing resistance to drugs due to irregular and incomplete treatment with irrational regimens. &amp;quot;This is being dealt with through appropriate expansion of diagnostic and treatment services.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;However, WHO said that for patients who had started treatment, India&#039;s programme provided one full course of drugs for each patient. This ensured that there was no interruption of treatment due to drug shortage. Hence, the fear that there could be interruption of treatment leading to development of drug resistance was unfounded. &amp;quot;It is reassuring to note that the Government of India has taken urgent action,&amp;quot; Dr. Menabde said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;India has one of the largest TB control programmes in the world with nearly 1.5 million patients placed under treatment every year. The treatment protocol ensures that the whole course of anti-TB drugs is given free of cost to patients with intense monitoring and other patient support systems.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Since inception, the Revised National TB Control Programme has evaluated over 55 million persons for TB and initiated treatment for over 15.8 million patients. There has never been any shortage of drugs in the programme due to a robust drug forecasting, procurement and distribution system&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The programme ventured on a rapid scale-up for rolling out drug-resistant TB management services and by March 2013 this service was made available to the entire population of the country. &lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/azad-says-no-shortage-of-tb-drugs-who-for-regimen-change-aarti-dhar-21653.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Azad says no shortage of TB drugs; WHO for regimen change-Aarti Dhar | Im4change.org</title>
    <meta name="description" content="
-The Hindu



Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.


One of the..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Azad says no shortage of TB drugs; WHO for regimen change-Aarti Dhar</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Hindu</div><p align="justify"><br />Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.</p><p align="justify">One of the challenges in anti-TB drugs procurement is that only a few manufacturers produce the particular regimen used by India's programme, which is of intermittent schedule. &quot;WHO currently recommends governments to consider changing the regimen from intermittent to daily,&quot; WHO Representative to India Nata Menabde said in a statement issued here.</p><p align="justify">WHO understood there was no drugs stock-out for adult patients for both drug-sensitive and drug-resistant TB at present. However, there was a dip in the buffer stock of drugs. &quot;We understand that the government has initiated steps to ensure replenishment. Also the stock of paediatric drugs, which is critically low, is being augmented through emergency procurement,&quot; Dr. Menadbe said.</p><p align="justify">Health and Family Welfare Minister Ghulam Nabi Azad said, &quot;At present there is no shortage. We always keep standby arrangements and we are providing medicines from that stock. Orders have been placed and within a month supplies will be made available to the States,&quot; he said after inaugurating a private ward at the LRS Institute of Tuberculosis and Respiratory Diseases here.</p><p align="justify">He, however, acknowledged that despite socio-economic development and advances in medical science, tuberculosis still remained a major public health concern globally.</p><p align="justify">Drug resistance</p><p align="justify">Another challenge of great concern, Mr Azad said, was the growing resistance to drugs due to irregular and incomplete treatment with irrational regimens. &quot;This is being dealt with through appropriate expansion of diagnostic and treatment services.&quot;</p><p align="justify">However, WHO said that for patients who had started treatment, India's programme provided one full course of drugs for each patient. This ensured that there was no interruption of treatment due to drug shortage. Hence, the fear that there could be interruption of treatment leading to development of drug resistance was unfounded. &quot;It is reassuring to note that the Government of India has taken urgent action,&quot; Dr. Menabde said.</p><p align="justify">India has one of the largest TB control programmes in the world with nearly 1.5 million patients placed under treatment every year. The treatment protocol ensures that the whole course of anti-TB drugs is given free of cost to patients with intense monitoring and other patient support systems.</p><p align="justify">Since inception, the Revised National TB Control Programme has evaluated over 55 million persons for TB and initiated treatment for over 15.8 million patients. There has never been any shortage of drugs in the programme due to a robust drug forecasting, procurement and distribution system</p><p align="justify">The programme ventured on a rapid scale-up for rolling out drug-resistant TB management services and by March 2013 this service was made available to the entire population of the country. </p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2478394a55-trace').style.display = (document.getElementById('cakeErr67f2478394a55-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f2478394a55-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2478394a55-code').style.display = (document.getElementById('cakeErr67f2478394a55-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f2478394a55-context').style.display = (document.getElementById('cakeErr67f2478394a55-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f2478394a55-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f2478394a55-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 21506,
		&#039;title&#039; =&gt; &#039;Azad says no shortage of TB drugs; WHO for regimen change-Aarti Dhar&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
One of the challenges in anti-TB drugs procurement is that only a few manufacturers produce the particular regimen used by India&#039;s programme, which is of intermittent schedule. &amp;quot;WHO currently recommends governments to consider changing the regimen from intermittent to daily,&amp;quot; WHO Representative to India Nata Menabde said in a statement issued here.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
WHO understood there was no drugs stock-out for adult patients for both drug-sensitive and drug-resistant TB at present. However, there was a dip in the buffer stock of drugs. &amp;quot;We understand that the government has initiated steps to ensure replenishment. Also the stock of paediatric drugs, which is critically low, is being augmented through emergency procurement,&amp;quot; Dr. Menadbe said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Health and Family Welfare Minister Ghulam Nabi Azad said, &amp;quot;At present there is no shortage. We always keep standby arrangements and we are providing medicines from that stock. Orders have been placed and within a month supplies will be made available to the States,&amp;quot; he said after inaugurating a private ward at the LRS Institute of Tuberculosis and Respiratory Diseases here.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
He, however, acknowledged that despite socio-economic development and advances in medical science, tuberculosis still remained a major public health concern globally.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Drug resistance
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Another challenge of great concern, Mr Azad said, was the growing resistance to drugs due to irregular and incomplete treatment with irrational regimens. &amp;quot;This is being dealt with through appropriate expansion of diagnostic and treatment services.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
However, WHO said that for patients who had started treatment, India&#039;s programme provided one full course of drugs for each patient. This ensured that there was no interruption of treatment due to drug shortage. Hence, the fear that there could be interruption of treatment leading to development of drug resistance was unfounded. &amp;quot;It is reassuring to note that the Government of India has taken urgent action,&amp;quot; Dr. Menabde said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
India has one of the largest TB control programmes in the world with nearly 1.5 million patients placed under treatment every year. The treatment protocol ensures that the whole course of anti-TB drugs is given free of cost to patients with intense monitoring and other patient support systems.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Since inception, the Revised National TB Control Programme has evaluated over 55 million persons for TB and initiated treatment for over 15.8 million patients. There has never been any shortage of drugs in the programme due to a robust drug forecasting, procurement and distribution system
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The programme ventured on a rapid scale-up for rolling out drug-resistant TB management services and by March 2013 this service was made available to the entire population of the country. 
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu, 21 June, 2013, http://www.thehindu.com/sci-tech/health/medicine-and-research/no-shortage-of-tuberculosis-drugs-azad/article4837233.ece?homepage=true&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;azad-says-no-shortage-of-tb-drugs-who-for-regimen-change-aarti-dhar-21653&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 21653,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 21506,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Azad says no shortage of TB drugs; WHO for regimen change-Aarti Dhar&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Tuberculosis,Health,medicines&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Hindu



Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.


One of the...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;One of the challenges in anti-TB drugs procurement is that only a few manufacturers produce the particular regimen used by India&#039;s programme, which is of intermittent schedule. &amp;quot;WHO currently recommends governments to consider changing the regimen from intermittent to daily,&amp;quot; WHO Representative to India Nata Menabde said in a statement issued here.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;WHO understood there was no drugs stock-out for adult patients for both drug-sensitive and drug-resistant TB at present. However, there was a dip in the buffer stock of drugs. &amp;quot;We understand that the government has initiated steps to ensure replenishment. Also the stock of paediatric drugs, which is critically low, is being augmented through emergency procurement,&amp;quot; Dr. Menadbe said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Health and Family Welfare Minister Ghulam Nabi Azad said, &amp;quot;At present there is no shortage. We always keep standby arrangements and we are providing medicines from that stock. Orders have been placed and within a month supplies will be made available to the States,&amp;quot; he said after inaugurating a private ward at the LRS Institute of Tuberculosis and Respiratory Diseases here.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;He, however, acknowledged that despite socio-economic development and advances in medical science, tuberculosis still remained a major public health concern globally.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Drug resistance&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Another challenge of great concern, Mr Azad said, was the growing resistance to drugs due to irregular and incomplete treatment with irrational regimens. &amp;quot;This is being dealt with through appropriate expansion of diagnostic and treatment services.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;However, WHO said that for patients who had started treatment, India&#039;s programme provided one full course of drugs for each patient. This ensured that there was no interruption of treatment due to drug shortage. Hence, the fear that there could be interruption of treatment leading to development of drug resistance was unfounded. &amp;quot;It is reassuring to note that the Government of India has taken urgent action,&amp;quot; Dr. Menabde said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;India has one of the largest TB control programmes in the world with nearly 1.5 million patients placed under treatment every year. The treatment protocol ensures that the whole course of anti-TB drugs is given free of cost to patients with intense monitoring and other patient support systems.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Since inception, the Revised National TB Control Programme has evaluated over 55 million persons for TB and initiated treatment for over 15.8 million patients. There has never been any shortage of drugs in the programme due to a robust drug forecasting, procurement and distribution system&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The programme ventured on a rapid scale-up for rolling out drug-resistant TB management services and by March 2013 this service was made available to the entire population of the country. &lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 21506,
	&#039;title&#039; =&gt; &#039;Azad says no shortage of TB drugs; WHO for regimen change-Aarti Dhar&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu
&lt;/div&gt;
&lt;p align=&quot;justify&quot;&gt;
&lt;br /&gt;
Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
One of the challenges in anti-TB drugs procurement is that only a few manufacturers produce the particular regimen used by India&#039;s programme, which is of intermittent schedule. &amp;quot;WHO currently recommends governments to consider changing the regimen from intermittent to daily,&amp;quot; WHO Representative to India Nata Menabde said in a statement issued here.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
WHO understood there was no drugs stock-out for adult patients for both drug-sensitive and drug-resistant TB at present. However, there was a dip in the buffer stock of drugs. &amp;quot;We understand that the government has initiated steps to ensure replenishment. Also the stock of paediatric drugs, which is critically low, is being augmented through emergency procurement,&amp;quot; Dr. Menadbe said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Health and Family Welfare Minister Ghulam Nabi Azad said, &amp;quot;At present there is no shortage. We always keep standby arrangements and we are providing medicines from that stock. Orders have been placed and within a month supplies will be made available to the States,&amp;quot; he said after inaugurating a private ward at the LRS Institute of Tuberculosis and Respiratory Diseases here.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
He, however, acknowledged that despite socio-economic development and advances in medical science, tuberculosis still remained a major public health concern globally.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Drug resistance
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Another challenge of great concern, Mr Azad said, was the growing resistance to drugs due to irregular and incomplete treatment with irrational regimens. &amp;quot;This is being dealt with through appropriate expansion of diagnostic and treatment services.&amp;quot;
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
However, WHO said that for patients who had started treatment, India&#039;s programme provided one full course of drugs for each patient. This ensured that there was no interruption of treatment due to drug shortage. Hence, the fear that there could be interruption of treatment leading to development of drug resistance was unfounded. &amp;quot;It is reassuring to note that the Government of India has taken urgent action,&amp;quot; Dr. Menabde said.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
India has one of the largest TB control programmes in the world with nearly 1.5 million patients placed under treatment every year. The treatment protocol ensures that the whole course of anti-TB drugs is given free of cost to patients with intense monitoring and other patient support systems.
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
Since inception, the Revised National TB Control Programme has evaluated over 55 million persons for TB and initiated treatment for over 15.8 million patients. There has never been any shortage of drugs in the programme due to a robust drug forecasting, procurement and distribution system
&lt;/p&gt;
&lt;p align=&quot;justify&quot;&gt;
The programme ventured on a rapid scale-up for rolling out drug-resistant TB management services and by March 2013 this service was made available to the entire population of the country. 
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu, 21 June, 2013, http://www.thehindu.com/sci-tech/health/medicine-and-research/no-shortage-of-tuberculosis-drugs-azad/article4837233.ece?homepage=true&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;azad-says-no-shortage-of-tb-drugs-who-for-regimen-change-aarti-dhar-21653&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 21653,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 21506
$metaTitle = &#039;LATEST NEWS UPDATES | Azad says no shortage of TB drugs; WHO for regimen change-Aarti Dhar&#039;
$metaKeywords = &#039;Tuberculosis,Health,medicines&#039;
$metaDesc = &#039;
-The Hindu



Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.


One of the...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu&lt;/div&gt;&lt;p align=&quot;justify&quot;&gt;&lt;br /&gt;Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;One of the challenges in anti-TB drugs procurement is that only a few manufacturers produce the particular regimen used by India&#039;s programme, which is of intermittent schedule. &amp;quot;WHO currently recommends governments to consider changing the regimen from intermittent to daily,&amp;quot; WHO Representative to India Nata Menabde said in a statement issued here.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;WHO understood there was no drugs stock-out for adult patients for both drug-sensitive and drug-resistant TB at present. However, there was a dip in the buffer stock of drugs. &amp;quot;We understand that the government has initiated steps to ensure replenishment. Also the stock of paediatric drugs, which is critically low, is being augmented through emergency procurement,&amp;quot; Dr. Menadbe said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Health and Family Welfare Minister Ghulam Nabi Azad said, &amp;quot;At present there is no shortage. We always keep standby arrangements and we are providing medicines from that stock. Orders have been placed and within a month supplies will be made available to the States,&amp;quot; he said after inaugurating a private ward at the LRS Institute of Tuberculosis and Respiratory Diseases here.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;He, however, acknowledged that despite socio-economic development and advances in medical science, tuberculosis still remained a major public health concern globally.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Drug resistance&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Another challenge of great concern, Mr Azad said, was the growing resistance to drugs due to irregular and incomplete treatment with irrational regimens. &amp;quot;This is being dealt with through appropriate expansion of diagnostic and treatment services.&amp;quot;&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;However, WHO said that for patients who had started treatment, India&#039;s programme provided one full course of drugs for each patient. This ensured that there was no interruption of treatment due to drug shortage. Hence, the fear that there could be interruption of treatment leading to development of drug resistance was unfounded. &amp;quot;It is reassuring to note that the Government of India has taken urgent action,&amp;quot; Dr. Menabde said.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;India has one of the largest TB control programmes in the world with nearly 1.5 million patients placed under treatment every year. The treatment protocol ensures that the whole course of anti-TB drugs is given free of cost to patients with intense monitoring and other patient support systems.&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;Since inception, the Revised National TB Control Programme has evaluated over 55 million persons for TB and initiated treatment for over 15.8 million patients. There has never been any shortage of drugs in the programme due to a robust drug forecasting, procurement and distribution system&lt;/p&gt;&lt;p align=&quot;justify&quot;&gt;The programme ventured on a rapid scale-up for rolling out drug-resistant TB management services and by March 2013 this service was made available to the entire population of the country. &lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/azad-says-no-shortage-of-tb-drugs-who-for-regimen-change-aarti-dhar-21653.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Azad says no shortage of TB drugs; WHO for regimen change-Aarti Dhar | Im4change.org</title>
    <meta name="description" content="
-The Hindu



Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.


One of the..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Azad says no shortage of TB drugs; WHO for regimen change-Aarti Dhar</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Hindu</div><p align="justify"><br />Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.</p><p align="justify">One of the challenges in anti-TB drugs procurement is that only a few manufacturers produce the particular regimen used by India's programme, which is of intermittent schedule. &quot;WHO currently recommends governments to consider changing the regimen from intermittent to daily,&quot; WHO Representative to India Nata Menabde said in a statement issued here.</p><p align="justify">WHO understood there was no drugs stock-out for adult patients for both drug-sensitive and drug-resistant TB at present. However, there was a dip in the buffer stock of drugs. &quot;We understand that the government has initiated steps to ensure replenishment. Also the stock of paediatric drugs, which is critically low, is being augmented through emergency procurement,&quot; Dr. Menadbe said.</p><p align="justify">Health and Family Welfare Minister Ghulam Nabi Azad said, &quot;At present there is no shortage. We always keep standby arrangements and we are providing medicines from that stock. Orders have been placed and within a month supplies will be made available to the States,&quot; he said after inaugurating a private ward at the LRS Institute of Tuberculosis and Respiratory Diseases here.</p><p align="justify">He, however, acknowledged that despite socio-economic development and advances in medical science, tuberculosis still remained a major public health concern globally.</p><p align="justify">Drug resistance</p><p align="justify">Another challenge of great concern, Mr Azad said, was the growing resistance to drugs due to irregular and incomplete treatment with irrational regimens. &quot;This is being dealt with through appropriate expansion of diagnostic and treatment services.&quot;</p><p align="justify">However, WHO said that for patients who had started treatment, India's programme provided one full course of drugs for each patient. This ensured that there was no interruption of treatment due to drug shortage. Hence, the fear that there could be interruption of treatment leading to development of drug resistance was unfounded. &quot;It is reassuring to note that the Government of India has taken urgent action,&quot; Dr. Menabde said.</p><p align="justify">India has one of the largest TB control programmes in the world with nearly 1.5 million patients placed under treatment every year. The treatment protocol ensures that the whole course of anti-TB drugs is given free of cost to patients with intense monitoring and other patient support systems.</p><p align="justify">Since inception, the Revised National TB Control Programme has evaluated over 55 million persons for TB and initiated treatment for over 15.8 million patients. There has never been any shortage of drugs in the programme due to a robust drug forecasting, procurement and distribution system</p><p align="justify">The programme ventured on a rapid scale-up for rolling out drug-resistant TB management services and by March 2013 this service was made available to the entire population of the country. </p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 21506,
		'title' => 'Azad says no shortage of TB drugs; WHO for regimen change-Aarti Dhar',
		'subheading' => '',
		'description' => '<div align="justify">
-The Hindu
</div>
<p align="justify">
<br />
Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.
</p>
<p align="justify">
One of the challenges in anti-TB drugs procurement is that only a few manufacturers produce the particular regimen used by India's programme, which is of intermittent schedule. &quot;WHO currently recommends governments to consider changing the regimen from intermittent to daily,&quot; WHO Representative to India Nata Menabde said in a statement issued here.
</p>
<p align="justify">
WHO understood there was no drugs stock-out for adult patients for both drug-sensitive and drug-resistant TB at present. However, there was a dip in the buffer stock of drugs. &quot;We understand that the government has initiated steps to ensure replenishment. Also the stock of paediatric drugs, which is critically low, is being augmented through emergency procurement,&quot; Dr. Menadbe said.
</p>
<p align="justify">
Health and Family Welfare Minister Ghulam Nabi Azad said, &quot;At present there is no shortage. We always keep standby arrangements and we are providing medicines from that stock. Orders have been placed and within a month supplies will be made available to the States,&quot; he said after inaugurating a private ward at the LRS Institute of Tuberculosis and Respiratory Diseases here.
</p>
<p align="justify">
He, however, acknowledged that despite socio-economic development and advances in medical science, tuberculosis still remained a major public health concern globally.
</p>
<p align="justify">
Drug resistance
</p>
<p align="justify">
Another challenge of great concern, Mr Azad said, was the growing resistance to drugs due to irregular and incomplete treatment with irrational regimens. &quot;This is being dealt with through appropriate expansion of diagnostic and treatment services.&quot;
</p>
<p align="justify">
However, WHO said that for patients who had started treatment, India's programme provided one full course of drugs for each patient. This ensured that there was no interruption of treatment due to drug shortage. Hence, the fear that there could be interruption of treatment leading to development of drug resistance was unfounded. &quot;It is reassuring to note that the Government of India has taken urgent action,&quot; Dr. Menabde said.
</p>
<p align="justify">
India has one of the largest TB control programmes in the world with nearly 1.5 million patients placed under treatment every year. The treatment protocol ensures that the whole course of anti-TB drugs is given free of cost to patients with intense monitoring and other patient support systems.
</p>
<p align="justify">
Since inception, the Revised National TB Control Programme has evaluated over 55 million persons for TB and initiated treatment for over 15.8 million patients. There has never been any shortage of drugs in the programme due to a robust drug forecasting, procurement and distribution system
</p>
<p align="justify">
The programme ventured on a rapid scale-up for rolling out drug-resistant TB management services and by March 2013 this service was made available to the entire population of the country. 
</p>',
		'credit_writer' => 'The Hindu, 21 June, 2013, http://www.thehindu.com/sci-tech/health/medicine-and-research/no-shortage-of-tuberculosis-drugs-azad/article4837233.ece?homepage=true',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'azad-says-no-shortage-of-tb-drugs-who-for-regimen-change-aarti-dhar-21653',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 21653,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 21506,
	'metaTitle' => 'LATEST NEWS UPDATES | Azad says no shortage of TB drugs; WHO for regimen change-Aarti Dhar',
	'metaKeywords' => 'Tuberculosis,Health,medicines',
	'metaDesc' => '
-The Hindu



Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.


One of the...',
	'disp' => '<div align="justify">-The Hindu</div><p align="justify"><br />Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.</p><p align="justify">One of the challenges in anti-TB drugs procurement is that only a few manufacturers produce the particular regimen used by India's programme, which is of intermittent schedule. &quot;WHO currently recommends governments to consider changing the regimen from intermittent to daily,&quot; WHO Representative to India Nata Menabde said in a statement issued here.</p><p align="justify">WHO understood there was no drugs stock-out for adult patients for both drug-sensitive and drug-resistant TB at present. However, there was a dip in the buffer stock of drugs. &quot;We understand that the government has initiated steps to ensure replenishment. Also the stock of paediatric drugs, which is critically low, is being augmented through emergency procurement,&quot; Dr. Menadbe said.</p><p align="justify">Health and Family Welfare Minister Ghulam Nabi Azad said, &quot;At present there is no shortage. We always keep standby arrangements and we are providing medicines from that stock. Orders have been placed and within a month supplies will be made available to the States,&quot; he said after inaugurating a private ward at the LRS Institute of Tuberculosis and Respiratory Diseases here.</p><p align="justify">He, however, acknowledged that despite socio-economic development and advances in medical science, tuberculosis still remained a major public health concern globally.</p><p align="justify">Drug resistance</p><p align="justify">Another challenge of great concern, Mr Azad said, was the growing resistance to drugs due to irregular and incomplete treatment with irrational regimens. &quot;This is being dealt with through appropriate expansion of diagnostic and treatment services.&quot;</p><p align="justify">However, WHO said that for patients who had started treatment, India's programme provided one full course of drugs for each patient. This ensured that there was no interruption of treatment due to drug shortage. Hence, the fear that there could be interruption of treatment leading to development of drug resistance was unfounded. &quot;It is reassuring to note that the Government of India has taken urgent action,&quot; Dr. Menabde said.</p><p align="justify">India has one of the largest TB control programmes in the world with nearly 1.5 million patients placed under treatment every year. The treatment protocol ensures that the whole course of anti-TB drugs is given free of cost to patients with intense monitoring and other patient support systems.</p><p align="justify">Since inception, the Revised National TB Control Programme has evaluated over 55 million persons for TB and initiated treatment for over 15.8 million patients. There has never been any shortage of drugs in the programme due to a robust drug forecasting, procurement and distribution system</p><p align="justify">The programme ventured on a rapid scale-up for rolling out drug-resistant TB management services and by March 2013 this service was made available to the entire population of the country. </p>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 21506,
	'title' => 'Azad says no shortage of TB drugs; WHO for regimen change-Aarti Dhar',
	'subheading' => '',
	'description' => '<div align="justify">
-The Hindu
</div>
<p align="justify">
<br />
Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.
</p>
<p align="justify">
One of the challenges in anti-TB drugs procurement is that only a few manufacturers produce the particular regimen used by India's programme, which is of intermittent schedule. &quot;WHO currently recommends governments to consider changing the regimen from intermittent to daily,&quot; WHO Representative to India Nata Menabde said in a statement issued here.
</p>
<p align="justify">
WHO understood there was no drugs stock-out for adult patients for both drug-sensitive and drug-resistant TB at present. However, there was a dip in the buffer stock of drugs. &quot;We understand that the government has initiated steps to ensure replenishment. Also the stock of paediatric drugs, which is critically low, is being augmented through emergency procurement,&quot; Dr. Menadbe said.
</p>
<p align="justify">
Health and Family Welfare Minister Ghulam Nabi Azad said, &quot;At present there is no shortage. We always keep standby arrangements and we are providing medicines from that stock. Orders have been placed and within a month supplies will be made available to the States,&quot; he said after inaugurating a private ward at the LRS Institute of Tuberculosis and Respiratory Diseases here.
</p>
<p align="justify">
He, however, acknowledged that despite socio-economic development and advances in medical science, tuberculosis still remained a major public health concern globally.
</p>
<p align="justify">
Drug resistance
</p>
<p align="justify">
Another challenge of great concern, Mr Azad said, was the growing resistance to drugs due to irregular and incomplete treatment with irrational regimens. &quot;This is being dealt with through appropriate expansion of diagnostic and treatment services.&quot;
</p>
<p align="justify">
However, WHO said that for patients who had started treatment, India's programme provided one full course of drugs for each patient. This ensured that there was no interruption of treatment due to drug shortage. Hence, the fear that there could be interruption of treatment leading to development of drug resistance was unfounded. &quot;It is reassuring to note that the Government of India has taken urgent action,&quot; Dr. Menabde said.
</p>
<p align="justify">
India has one of the largest TB control programmes in the world with nearly 1.5 million patients placed under treatment every year. The treatment protocol ensures that the whole course of anti-TB drugs is given free of cost to patients with intense monitoring and other patient support systems.
</p>
<p align="justify">
Since inception, the Revised National TB Control Programme has evaluated over 55 million persons for TB and initiated treatment for over 15.8 million patients. There has never been any shortage of drugs in the programme due to a robust drug forecasting, procurement and distribution system
</p>
<p align="justify">
The programme ventured on a rapid scale-up for rolling out drug-resistant TB management services and by March 2013 this service was made available to the entire population of the country. 
</p>',
	'credit_writer' => 'The Hindu, 21 June, 2013, http://www.thehindu.com/sci-tech/health/medicine-and-research/no-shortage-of-tuberculosis-drugs-azad/article4837233.ece?homepage=true',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'azad-says-no-shortage-of-tb-drugs-who-for-regimen-change-aarti-dhar-21653',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 21653,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 21506
$metaTitle = 'LATEST NEWS UPDATES | Azad says no shortage of TB drugs; WHO for regimen change-Aarti Dhar'
$metaKeywords = 'Tuberculosis,Health,medicines'
$metaDesc = '
-The Hindu



Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.


One of the...'
$disp = '<div align="justify">-The Hindu</div><p align="justify"><br />Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses.</p><p align="justify">One of the challenges in anti-TB drugs procurement is that only a few manufacturers produce the particular regimen used by India's programme, which is of intermittent schedule. &quot;WHO currently recommends governments to consider changing the regimen from intermittent to daily,&quot; WHO Representative to India Nata Menabde said in a statement issued here.</p><p align="justify">WHO understood there was no drugs stock-out for adult patients for both drug-sensitive and drug-resistant TB at present. However, there was a dip in the buffer stock of drugs. &quot;We understand that the government has initiated steps to ensure replenishment. Also the stock of paediatric drugs, which is critically low, is being augmented through emergency procurement,&quot; Dr. Menadbe said.</p><p align="justify">Health and Family Welfare Minister Ghulam Nabi Azad said, &quot;At present there is no shortage. We always keep standby arrangements and we are providing medicines from that stock. Orders have been placed and within a month supplies will be made available to the States,&quot; he said after inaugurating a private ward at the LRS Institute of Tuberculosis and Respiratory Diseases here.</p><p align="justify">He, however, acknowledged that despite socio-economic development and advances in medical science, tuberculosis still remained a major public health concern globally.</p><p align="justify">Drug resistance</p><p align="justify">Another challenge of great concern, Mr Azad said, was the growing resistance to drugs due to irregular and incomplete treatment with irrational regimens. &quot;This is being dealt with through appropriate expansion of diagnostic and treatment services.&quot;</p><p align="justify">However, WHO said that for patients who had started treatment, India's programme provided one full course of drugs for each patient. This ensured that there was no interruption of treatment due to drug shortage. Hence, the fear that there could be interruption of treatment leading to development of drug resistance was unfounded. &quot;It is reassuring to note that the Government of India has taken urgent action,&quot; Dr. Menabde said.</p><p align="justify">India has one of the largest TB control programmes in the world with nearly 1.5 million patients placed under treatment every year. The treatment protocol ensures that the whole course of anti-TB drugs is given free of cost to patients with intense monitoring and other patient support systems.</p><p align="justify">Since inception, the Revised National TB Control Programme has evaluated over 55 million persons for TB and initiated treatment for over 15.8 million patients. There has never been any shortage of drugs in the programme due to a robust drug forecasting, procurement and distribution system</p><p align="justify">The programme ventured on a rapid scale-up for rolling out drug-resistant TB management services and by March 2013 this service was made available to the entire population of the country. </p>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Azad says no shortage of TB drugs; WHO for regimen change-Aarti Dhar

-The Hindu Even as the Union government rejected reports of shortage of tuberculosis drugs, saying fresh stocks will arrive by July-end, World Health Organisation (WHO) on Friday asked India to consider changing the regimen from intermittent to daily doses. One of the challenges in anti-TB drugs procurement is that only a few manufacturers produce the particular regimen used by India's programme, which is of intermittent schedule. "WHO currently recommends governments to consider changing the regimen from intermittent to daily," WHO Representative to India Nata Menabde said in a statement issued here. WHO understood there was no drugs stock-out for adult patients for both drug-sensitive and drug-resistant TB at present. However, there was a dip in the buffer stock of drugs. "We understand that the government has initiated steps to ensure replenishment. Also the stock of paediatric drugs, which is critically low, is being augmented through emergency procurement," Dr. Menadbe said. Health and Family Welfare Minister Ghulam Nabi Azad said, "At present there is no shortage. We always keep standby arrangements and we are providing medicines from that stock. Orders have been placed and within a month supplies will be made available to the States," he said after inaugurating a private ward at the LRS Institute of Tuberculosis and Respiratory Diseases here. He, however, acknowledged that despite socio-economic development and advances in medical science, tuberculosis still remained a major public health concern globally. Drug resistance Another challenge of great concern, Mr Azad said, was the growing resistance to drugs due to irregular and incomplete treatment with irrational regimens. "This is being dealt with through appropriate expansion of diagnostic and treatment services." However, WHO said that for patients who had started treatment, India's programme provided one full course of drugs for each patient. This ensured that there was no interruption of treatment due to drug shortage. Hence, the fear that there could be interruption of treatment leading to development of drug resistance was unfounded. "It is reassuring to note that the Government of India has taken urgent action," Dr. Menabde said. India has one of the largest TB control programmes in the world with nearly 1.5 million patients placed under treatment every year. The treatment protocol ensures that the whole course of anti-TB drugs is given free of cost to patients with intense monitoring and other patient support systems. Since inception, the Revised National TB Control Programme has evaluated over 55 million persons for TB and initiated treatment for over 15.8 million patients. There has never been any shortage of drugs in the programme due to a robust drug forecasting, procurement and distribution system The programme ventured on a rapid scale-up for rolling out drug-resistant TB management services and by March 2013 this service was made available to the entire population of the country.